Scientists have linked mutations in 11 genes with aggressive prostate cancer, according to the largest-ever study of its kind recently published in JAMA Oncology.
Combining immunotherapy with radiation may be a promising treatment option for patients with advanced soft tissue sarcoma, according to the results of a Northwestern Medicine clinical trial published in JAMA Oncology.
More than 400 alumni and guests convened at the annual Alumni Weekend to reconnect and reminisce with former classmates about their time at Feinberg and learn about the medical school’s latest achievements.
Northwestern Medicine scientists have identified how cytoskeletal proteins contribute to the growth of developing eggs in fruit flies, findings which further the understanding of how egg cells form and differentiate themselves from other cells, according to a study published in the Proceedings of the National Academy of Sciences.
Northwestern University Feinberg School of Medicine has launched a new master’s degree program in Health Professions Education designed to give healthcare professionals the tools to be leaders in how healthcare is taught and practiced.
The antidiabetic and weight loss drug semaglutide, sold under the brand names Ozempic and Wegovy, can also help patients with heart failure and obesity lose weight while also improving symptoms and increasing exercise capacity, according to a clinical trial published in the New England Journal of Medicine.
D. James Surmeier, PhD, the Nathan Smith Davis Professor and chair of Neuroscience, has been named the recipient of the 2023 Annemarie Opprecht Parkinson Award, an international award recognizing significant contributions to the field of Parkinson’s disease research.
Faculty, staff, trainees and students gathered to share knowledge and participate in workshops examining the future of medical education during Feinberg’s 13th annual Medical Education Day, held September 27.
Northwestern Medicine scientists have identified how one gene connects glioblastoma stem cell self-renewal to microglia immunosuppression in glioblastoma, according to a new study published in Nature Immunology.
In 2022, Feinberg established research into social determinants of health as a priority. To better understand the impact of social determinants of health, Feinberg investigators have been leading studies that provide new insights into how a person’s neighborhood can positively or negatively affect their health.